Fabino Enter

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DRT01018
  • NSEID:
  • BSEID: 543444
INR
16.75
0.00 (0.00%)
BSENSE

Dec 24

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.0 k (150.00%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

56.82%

Who are in the management team of Fabino Enter?

06-Jun-2025

As of March 2023, the management team of Fabino Enter includes Atul Jain (CMD & Executive Director), Aditya Mahavir Jain (Executive Director & Wholetime Director), Arihant Jain (Non-Executive Director), Tesu Alakh (Independent Non-Executive Director), Gagan Gupta (Independent Non-Executive Director), and Sumit Malik (Non-Executive & Non-Independent Director). These individuals oversee the company's governance and strategic direction.

As of March 2023, the management team of Fabino Enter includes the following individuals:<BR><BR>1. Atul Jain - CMD & Executive Director<BR>2. Aditya Mahavir Jain - Executive Director & Wholetime Director<BR>3. Arihant Jain - Non-Executive Director<BR>4. Tesu Alakh - Independent Non-Executive Director<BR>5. Gagan Gupta - Independent Non-Executive Director<BR>6. Sumit Malik - Non-Executive & Non-Independent Director<BR><BR>These members form the board of directors, contributing to the governance and strategic direction of the company.

Read More

Has Fabino Enter declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Fabino Enter?

16-Jul-2025

Fabino Enter's peers include Unjha Formul., Beryl Drugs, Cian Healthcare, Adline Chem Lab, Ortin Global, Vivanza Biosci., Ganga Pharma., Brawn Biotech, and Shyama Computro. Unjha Formul. shows excellent management risk and the highest 1-year return at 23.34%, while Fabino Enter has average management risk and a 1-year return of -12.24%.

Peers: The peers of Fabino Enter are Unjha Formul., Beryl Drugs, Cian Healthcare, Adline Chem Lab, Ortin Global, Vivanza Biosci., Ganga Pharma., Brawn Biotech, Shyama Computro.<BR><BR>Quality Snapshot: Excellent management risk is observed at Unjha Formul., while Average management risk is found at Fabino Enter and the rest. Below Average management risk is noted for Beryl Drugs, Cian Healthcare, Ortin Global, Vivanza Biosci., Ganga Pharma., and Brawn Biotech. Adline Chem Lab and Shyama Computro. do not qualify for management risk assessment. Growth is Below Average for Fabino Enter, Beryl Drugs, Cian Healthcare, Ortin Global, Vivanza Biosci., Ganga Pharma., and Brawn Biotech, while Adline Chem Lab and Shyama Computro. do not qualify. Capital Structure is Good at Unjha Formul., Average at Fabino Enter, and Below Average for Beryl Drugs, Cian Healthcare, Ortin Global, Vivanza Biosci., Ganga Pharma., and Brawn Biotech, with Adline Chem Lab and Shyama Computro. not qualifying.<BR><BR>Return Snapshot: Unjha Formul. has the highest 1-year return at 23.34%, while Cian Healthcare has the lowest at -81.16%. Fabino Enter's 1-year return is -12.24%, which is better than Cian Healthcare but worse than Unjha Formul. Additionally, Beryl Drugs, Cian Healthcare, Ortin Global, Vivanza Biosci., Ganga Pharma., and Brawn Biotech all have negative six-month returns.

Read More

What does Fabino Enter do?

17-Jul-2025

Fabino Enterprises Ltd is a micro-cap pharmaceutical company, incorporated in 2011, with recent net sales of 11 Cr and a market cap of 6 Cr. It has a P/E ratio of 5.00 and a debt-equity ratio of 0.20.

Overview:<BR>Fabino Enterprises Ltd is a growing pharmaceutical company operating in the Micro Cap category within the Pharmaceuticals & Biotechnology industry.<BR><BR>History:<BR>Fabino Enterprises Ltd was incorporated as "Fabino Life Sciences Private Limited" in 2011 and later converted to a Public Limited Company, changing its name to "Fabino Life Sciences Limited" in 2015. The most recent quarterly results reported net sales and net profit for June 2021.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 11 Cr (Quarterly Results - Jun 2021) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2021) <BR>Market-cap value: INR 6 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 5.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.20 <BR>Return on Equity: 3.13% <BR>Price to Book: 1.35 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Read More

Who are the top shareholders of the Fabino Enter?

17-Jul-2025

The top shareholder of Fabino Enter is promoter Aditya Mahavir Jain, holding 52.38%. The highest public shareholder is Nopea Capital Services Private Limited at 4.71%, while individual investors collectively own 29.18% of the shares.

The top shareholders of Fabino Enter include Aditya Mahavir Jain, who is the promoter with the highest holding at 52.38%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors currently do not hold any shares in the company. The highest public shareholder is Nopea Capital Services Private Limited, holding 4.71%. Additionally, individual investors collectively hold 29.18% of the shares.

Read More

How big is Fabino Enter?

24-Jul-2025

As of 18th July, Fabino Enterprises Ltd has a market capitalization of 5.00 Cr, with recent net sales of 1.13 Cr and a net profit of 0.01 Cr for the quarter ending June 2021. The balance sheet for March 2024 shows shareholder's funds of 4.14 Cr and total assets of 15.35 Cr.

As of 18th July, Fabino Enterprises Ltd has a market capitalization of 5.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest quarter ending June 2021, Fabino Enterprises Ltd reported Net Sales of 1.13 Cr and a Net Profit of 0.01 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 4.14 Cr and Total Assets of 15.35 Cr.

Read More

Is Fabino Enter overvalued or undervalued?

09-Oct-2025

As of October 8, 2025, Fabino Enter is considered very expensive and overvalued, with a PE ratio of 4.83 and disappointing financial performance, including a year-to-date stock return of -30.09%, compared to the Sensex's 4.65% return.

As of 8 October 2025, the valuation grade for Fabino Enter has moved from risky to very expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 4.83, an EV to EBIT of 6.22, and a ROE of 3.03%. In comparison to its peers, Fabino Enter's PE ratio is significantly lower than Sun Pharma's 34.13 and Divi's Lab's 70.37, indicating that it is trading at a discount relative to these competitors despite its high valuation grade.<BR><BR>Fabino Enter's financial performance has been disappointing, as evidenced by a year-to-date stock return of -30.09%, contrasting sharply with the Sensex's positive return of 4.65% over the same period. This underperformance, combined with its very expensive valuation grade and low profitability ratios, further supports the conclusion that the company is overvalued in the current market environment.

Read More

When is the next results date for Fabino Enter?

11-Nov-2025

The next results date for Fabino Enter is 13 November 2025.

The next results date for Fabino Enter is scheduled for 13 November 2025.

Read More

How has been the historical performance of Fabino Enter?

13-Nov-2025

Fabino Enter's historical performance shows stable share capital and gradual increases in total reserves and shareholder's funds, but significant growth in long-term borrowings and total liabilities, with no reported profit or cash flows, indicating a lack of operational profitability. The book value per share slightly increased from Rs 19.59 to Rs 20.02 over the period.

Answer:<BR>The historical performance of Fabino Enter shows a consistent trend in its financial metrics over the past three years.<BR><BR>Breakdown:<BR>Fabino Enter's share capital has remained stable at Rs 2.10 crore from March 2023 to March 2025. Total reserves have shown a gradual increase, rising from Rs 2.01 crore in March 2023 to Rs 2.10 crore in March 2025. Shareholder's funds also increased slightly, from Rs 4.11 crore in March 2023 to Rs 4.20 crore in March 2025. Long-term borrowings have significantly increased, moving from Rs 0.41 crore in March 2023 to Rs 1.79 crore in March 2025, primarily due to an increase in unsecured loans. Total liabilities have risen sharply from Rs 5.00 crore in March 2023 to Rs 17.65 crore in March 2025, reflecting higher trade payables, which increased from Rs 0.37 crore to Rs 11.42 crore over the same period. Total assets have also grown, from Rs 5.00 crore in March 2023 to Rs 17.65 crore in March 2025, with total current assets increasing from Rs 4.78 crore to Rs 17.03 crore. However, the company has reported no profit before tax or cash flows from operating, investing, or financing activities during these years, indicating a lack of operational profitability. The book value per share has seen a slight increase from Rs 19.59 in March 2023 to Rs 20.02 in March 2025.

Read More

Why is Fabino Enter falling/rising?

21-Dec-2025

As of 21-Dec, Fabino Enterprises Ltd's stock price is Rs. 20.75, reflecting a significant decline of 23.15% over the past week and 36.93% year-to-date, while hitting a new all-time low. The stock's underperformance and trading below moving averages indicate a bearish trend, despite increased investor participation.

As of 21-Dec, Fabino Enterprises Ltd's stock price is currently at Rs. 20.75, showing no change from the previous trading session. The stock has experienced a significant decline, with a 1-week drop of 23.15% and a year-to-date decrease of 36.93%. Today, the stock hit a new 52-week and all-time low of Rs. 20.75, reflecting a substantial loss of 19.95% at the opening. <BR><BR>The stock has underperformed its sector by 19.56% today and has not traded on one day out of the last 20 days, indicating erratic trading behavior. Additionally, Fabino Enterprises is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend. <BR><BR>Despite these negative indicators, there has been a notable increase in investor participation, with delivery volume rising by 169.23% against the 5-day average on December 17. However, the overall liquidity remains low, as the stock is liquid enough for a trade size of Rs 0 crore based on 2% of the 5-day average traded value. <BR><BR>In summary, the combination of hitting a new low, significant declines over various periods, underperformance relative to the sector, and trading below moving averages contribute to the falling stock price of Fabino Enterprises Ltd.

Read More

Why is Fabino Enter falling/rising?

23-Dec-2025

As of 22-Dec, Fabino Enterprises Ltd is facing a significant decline in its stock price, currently at Rs. 20.75, marking a new all-time low. The stock has dropped 23.15% over the past week and 36.93% year-to-date, underperforming against the benchmark Sensex, indicating a bearish trend with no signs of recovery.

As of 22-Dec, Fabino Enterprises Ltd is experiencing a significant decline in its stock price. The current price is Rs. 20.75, which marks a new 52-week and all-time low for the stock. Today, the stock opened with a loss of 19.95% and has not traded above this price throughout the day, indicating a lack of upward momentum. <BR><BR>Over the past week, the stock has underperformed significantly, with a decline of 23.15%, while the benchmark Sensex has increased by 0.42%. This trend continues over longer periods, with the stock down 36.93% year-to-date compared to a 9.51% gain in the Sensex. Additionally, the stock has been trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further indicating a bearish trend.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 169.23% on December 17, this has not translated into a positive price movement. The erratic trading pattern, where the stock did not trade on one day out of the last 20, also contributes to the volatility and uncertainty surrounding the stock. Overall, the combination of poor performance relative to the market, significant price declines, and negative trading indicators suggests that Fabino Enterprises Ltd is currently in a downward trajectory.

Read More

Why is Fabino Enterprises Ltd falling/rising?

24-Dec-2025

As of 23-Dec, Fabino Enterprises Ltd's stock price has reached a new low of Rs. 20.75, reflecting a significant decline of 36.93% year-to-date. The stock has underperformed its sector and is trading below all key moving averages, indicating a persistent downward trend despite increased investor participation.

As of 23-Dec, Fabino Enterprises Ltd's stock price is falling. The current price is Rs. 20.75, which is the new 52-week and all-time low, indicating a significant decline. The stock has underperformed its sector by 19.56% today and opened with a substantial loss of 19.95%. Additionally, the stock has experienced a decline of 3.94% over the past week and 9.78% over the past month, while year-to-date, it has fallen by 36.93%. <BR><BR>The trading activity reflects this downward trend, as the stock did not trade on one day out of the last 20 days, and it is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite a rise in investor participation, with a delivery volume increase of 169.23% on December 17, the overall performance remains weak. The combination of these factors contributes to the stock's decline.

Read More

Why is Fabino Enterprises Ltd falling/rising?

25-Dec-2025

As of 24-Dec, Fabino Enterprises Ltd's stock price has significantly declined to Rs. 16.75, down 19.28%, with a year-to-date drop of 49.09%. This decline is driven by poor performance metrics, decreased investor interest, and persistent downward trading trends.

As of 24-Dec, Fabino Enterprises Ltd is experiencing a significant decline in its stock price, currently at Rs. 16.75, which reflects a change of -4.0 (-19.28%). This drop is attributed to several factors highlighted in the performance metrics. Over the past week, the stock has decreased by 35.38%, while its year-to-date performance shows a staggering decline of 49.09%, contrasting sharply with the Sensex, which has risen by 9.30% during the same period.<BR><BR>Today's trading activity indicates that the stock opened with a substantial loss of 19.28% and has not traded above this price, hitting a new 52-week low. The stock's performance today has underperformed its sector by 18.85%, and it has shown erratic trading patterns, not trading on three out of the last twenty days. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.<BR><BR>Investor participation has also decreased, with delivery volume dropping by 68.75% compared to the 5-day average, suggesting a lack of interest from investors. Overall, these factors contribute to the ongoing decline in Fabino Enterprises Ltd's stock price.

Read More

Why is Fabino Enterprises Ltd falling/rising?

25-Dec-2025

As of 25-Dec, Fabino Enterprises Ltd's stock price is Rs. 16.75, reflecting a significant decline of 19.28%. The stock has underperformed considerably, with a year-to-date decrease of 49.09% and trading below its moving averages, indicating a persistent downward trend.

As of 25-Dec, Fabino Enterprises Ltd's stock price is falling, currently at Rs. 16.75, which reflects a decrease of Rs. 4.0 or 19.28%. This decline is evident in the stock's performance over various periods, including a 1-week drop of 35.38% and a year-to-date decrease of 49.09%, significantly underperforming the Sensex, which has increased by 9.30% during the same timeframe.<BR><BR>Today's trading session highlights the stock's struggles, as it opened with a substantial loss of 19.28% and reached a new 52-week low of Rs. 16.75. The stock has not shown any price range, remaining stagnant at this low level throughout the day. Additionally, it has underperformed its sector by 18.85%. The trading activity has been erratic, with the stock not trading on 3 out of the last 20 days, and there has been a notable decline in investor participation, with delivery volume dropping by 68.75% compared to the 5-day average.<BR><BR>Moreover, the stock is trading below its moving averages across multiple timeframes, indicating a persistent downward trend. Overall, these factors contribute to the continued decline in Fabino Enterprises Ltd's stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 4 Cr (Micro Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.36

stock-summary
Return on Equity

3.22%

stock-summary
Price to Book

1.08

Revenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Jun 2021)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.93%
0%
-30.93%
6 Months
-45.62%
0%
-45.62%
1 Year
-46.05%
0%
-46.05%
2 Years
-39.09%
0%
-39.09%
3 Years
-47.66%
0%
-47.66%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Fabino Enter for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting & Submission Of Unaudited Financial Results For Half Year Ended September 30 2025

13-Nov-2025 | Source : BSE

1. The Unaudited Standalone Financial Results set out in compliance with Accounting Standards (AS) for the Half Year ended September 30 2025 together with Statement of Assets and Liabilities and Statement of Cash Flow. 2. The Unaudited Consolidated Financial Results set out in compliance with Accounting Standards (AS) for the Half Year ended September 30 2025 together with Statement of Assets and Liabilities and Statement of Cash Flow.

Results- Financial Results For The Half Year Ended September 30 2025

13-Nov-2025 | Source : BSE

Results- Financial results for the Half Year ended September 30 2025

Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For Half Year Ended September 30 2025

10-Nov-2025 | Source : BSE

Fabino Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for Half Year Ended September 30 2025 thereon and any other business with permission of Chair

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.10%
EBIT Growth (5y)
-4.36%
EBIT to Interest (avg)
0.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.36
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
2.19%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
0
Price to Book Value
0.87
EV to EBIT
4.96
EV to EBITDA
4.96
EV to Capital Employed
0.90
EV to Sales
0.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.82%
ROE (Latest)
3.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Aditya Mahavir Jain (52.38%)

Highest Public shareholder

Nopea Capital Services Private Limited (4.71%)

Individual Investors Holdings

28.75%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'21 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'21",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.13",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.03",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.01",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.65%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -51.89% vs 224.24% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -733.33% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.63",
          "val2": "13.78",
          "chgp": "-51.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.32",
          "val2": "0.07",
          "chgp": "-557.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.07",
          "chgp": "28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.19",
          "val2": "0.03",
          "chgp": "-733.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4.83%",
          "val2": "0.51%",
          "chgp": "-5.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'21",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Jun 2021 is -66.36% vs 159.90% in Jun 2021",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Jun 2021 is -500.00% vs 0.00% in Jun 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'21",
        "Jun'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.81",
          "val2": "5.38",
          "chgp": "-66.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.23",
          "val2": "0.06",
          "chgp": "-483.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.06",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.24",
          "val2": "0.06",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12.71%",
          "val2": "1.12%",
          "chgp": "-13.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -14.42% vs 527.38% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 50.00% vs 300.00% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.04",
          "val2": "21.08",
          "chgp": "-14.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.11",
          "val2": "0.11",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.13",
          "val2": "0.04",
          "chgp": "225.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.06",
          "val2": "0.04",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.61%",
          "val2": "0.52%",
          "chgp": "0.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'21 - QoQstock-summary
Jun'21
Change(%)
Net Sales
1.13
NA
NA
Operating Profit (PBDIT) excl Other Income
0.03
NA
NA
Interest
0.00
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
0.01
NA
NA
Operating Profit Margin (Excl OI)
2.65%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Mar'25
Change(%)
Net Sales
6.63
13.78
-51.89%
Operating Profit (PBDIT) excl Other Income
-0.32
0.07
-557.14%
Interest
0.09
0.07
28.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.19
0.03
-733.33%
Operating Profit Margin (Excl OI)
-4.83%
0.51%
-5.34%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -51.89% vs 224.24% in Mar 2025

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -733.33% vs 0.00% in Mar 2025

Nine Monthly Results Snapshot (Standalone) - Jun'21stock-summary
Jun'21
Jun'21
Change(%)
Net Sales
1.81
5.38
-66.36%
Operating Profit (PBDIT) excl Other Income
-0.23
0.06
-483.33%
Interest
0.08
0.06
33.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.24
0.06
-500.00%
Operating Profit Margin (Excl OI)
-12.71%
1.12%
-13.83%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Jun 2021 is -66.36% vs 159.90% in Jun 2021

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Jun 2021 is -500.00% vs 0.00% in Jun 2021

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
18.04
21.08
-14.42%
Operating Profit (PBDIT) excl Other Income
0.11
0.11
Interest
0.13
0.04
225.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.06
0.04
50.00%
Operating Profit Margin (Excl OI)
0.61%
0.52%
0.09%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -14.42% vs 527.38% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 50.00% vs 300.00% in Mar 2024

stock-summaryCompany CV
About Fabino Enterprises Ltd stock-summary
stock-summary
Fabino Enterprises Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as "Fabino Life Sciences Private Limited" on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to "Fabino Life Sciences Limited". A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi.
Company Coordinates stock-summary
Icon
No Company Details Available